Edward Y S Lin (Edward Lin)

Years Active: 2018-2023
Publications (10 Years): 2

Biogen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Biogen

United States

Scientist II :: Chemical and Molecular Therapeutics

Publications

Sangram Nag, Martin Bolin, Prodip Datta, Ryosuke Arakawa, Anton Forsberg Morén, Yasir Khani Maynaq, Edward Y S Lin, Nathan Genung, Heike Hering, Kevin Guckian, Laurent Martarello, Maciej Kaliszczak, Christer Halldin
Development of a Novel [ 11 C]CO-Labeled Positron Emission Tomography Radioligand [ 11 C]BIO-1819578 for the Detection of O -GlcNAcase Enzyme Activity. ACS chemical neuroscience (2023)
Edward Y S Lin, Laura F Silvian, Douglas J Marcotte, Charles C Banos, Flora Jow, Timothy R Chan, Robert M Arduini, Fang Qian, Darren P Baker, Chris Bergeron, Catherine A Hession, Richard L Huganir, Cassandra F Borenstein, Istvan Enyedy, Jinming Zou, Ellen Rohde, Marion Wittmann, Gnanasambandam Kumaravel, Kenneth J Rhodes, Robert H Scannevin, Anthone W Dunah, Kevin M Guckian
Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic Dysfunction. Scientific reports 8 (1) (2018)

Edward Y S Lin.css-eqlu8i{font-size:small;padding-left:4px;} (Edward Lin)